VENKATA VIJAYA KUMAR DALAI: Open Payments
NPI 1255741310 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,301 in 81 payments from 10 companies in 2025. Trend: 2023 $745 · 2024 $973 · 2025 $1,301
Food & beverage: $1,201Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $277 |
| JAZZ PHARMACEUTICALS INC. | 3 | $139 |
| Vanda Pharmaceuticals Inc. | 6 | $115 |
| Lundbeck LLC | 5 | $107 |
| Teva Pharmaceuticals USA, Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| Alkermes, Inc. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
Products named: VRAYLAR, CAPLYTA, REXULTI, XYWAV, AUSTEDO XR, ARISTADA, HETLIOZ, FANAPT.
Industry payments across AR — which companies pay providers there.
